On analysing European ophthalmology on the threshold of the third millennium, the epoch-making developments in diagnosis and therapy which have taken place mainly in the second half of the 20th century become apparent. Whereas in the 1960s ophthalmological knowledge was 30 years behind, it is now less than 5 years. The revolutionary age of electronic media and robots has arrived.
In medicine there is a long-term strategic dilemma which affects every country within the European Union, independent of politics, and would still be present if all the patients and doctors were angels and the medical industry were a branch of the Salvation Army. The dilemma is that modern medicine is becoming increasingly the victim of its own success. If today's medicine were not as efficient we would be spared many unpleasant decisions. In all EU states, the current health care system displays patient-oriented health promotion with a zero-cost mentality and no patient autonomy.
The health system
The majority of health systems in the EU do not yet deserve the description of "system" due to a lack of systematic interrelation. An integrated system should be developed from the collection of disjointed sectorial systems (the in and outpatient sectors, rehabilitation and care) the essential features of which can be introduced into every EU country and which is possible to finance.
The main problem in the member states is that of finance since the majority of statutory health insurance systems are financed either partially or completely by the taxpayer. This also means that the state, as legislative body and financial backer, exerts influence on the health care of its citizens. In order to shift costs and risks, however, states are increasingly tending to withdraw from the health system on an EU-wide level.
The present practice of finance from taxes and/or membership contributions is being changed step by step to an exclusive system of payments via health insurance companies. This would mean a monistic dependence on health insurance since he who pays exerts his influence on the health system.
The statutory health insurance companies are preparing themselves for a process of harmonization in Europe. It is their intention to turn from 'payer' to 'player' and to implement a global finance directive. A more efficient use of insurance contributions should ensure their aim of farreaching financial stability. This process will become a burden on the medical professions. The regulations for additional payments will be reorganized throughout the EU with regard to the autonomy of the patients. As well as basic insurance, in order to make modern medicine financially viable, there will be additional policies for all individuals, the scope of which can be organized according to individual needs. This form of health system is the objective of future EU member states such as Hungary, Poland, the Czech Republic and the Baltic states in anticipation of a pan-European health system. In Poland this development is already in progress.
Initial regional attempts at monistic integration have become apparent in several EU member states. New forms of outpatient care are appearing such as networks of practices interweaving general and specialist care and integrating the advanced medicine of clinics and hospitals, whereby specialists no longer work in independent practices but rather are integrated into the hospitals in outpatient departments. This system is already standard in the Netherlands.
It is not the amount of care but rather the quality of treatment within specific periods and the associated costs which will be decisive for the future success of organizational innovations in out-and inpatient departments. Therefore the "Ophthal-mological Practice Orientated Treatment Guidelines for Diagnosis and Therapy" were developed based on the "Preferred Practice Patterns" of the American Academy of Ophthalmology.
In the case of integrated practices, evaluation of health economy is in the interests of all parties concerned. The doctors participating in the integration are able to document quality and economy continually and therefore have a basis for fairer negotiations concerning payment with those bearing the costs. Hospitals should use the same argumentation.
On the other hand, health insurance companies can see how the insurance contributions are being spent. In this way, reasons for the competition between financiers would develop inasmuch as the present unified health insurers within the EU today were multiform following the German insurance system.
The doctor as service provider
Tempting as the role of health economy for system management may be, the doctor will become a medical manager. This is certainly already the case for those doctors who see their job principally as a means of making money rather than a way of serving the patients.
Some doctors turn their backs on the fundamental values of medical ethics and turn towards globalized capitalism. Capitalism is amoral, i.e. it remains neutral in the face of all moral questions. Questions of human worth -actually metaphysical questions -are discussed within this concept only to seek solutions to problems of economic success. In this way these doctors develop the wonderful ability to produce something like a manic obsession forgetting that capitalism in medicine avoids self-destruction only if it remains true to its legitimate incentive.
Medical treatment initially requires care in order to win the trust of the patient. Equipment and "hightech" medicine complement the doctor/patient relationship but are not capable of replacing it.
Personal care is not measurable in a health economic evaluation. Patient consultation is, however, a major issue which we must make the most of. This is the moral-ethical starting position with which we are confronted at the end of the second millennium where one can only make decisions for oneself.
University hospitals
The structure of the university hospitals must be revised and adapted to suit present requirements. Doctors function here not only in medical care but at the same time also as researchers and teachers.
The areas of research and teaching are increasingly being combined in the universities, whilst medical duties in the hospital and outpatient departments have separate financial arrangements and must be self-financing. In hospitals of the future a proportion of the doctors, including consultants, will be responsible for maximum medical care with no obligation to engage in research.
High-quality health care today requires complete commitment and continual further training. Even this is hardly possible during a normal working day according to "continuous medical education" (CME).
In a hospital where too many personnel are simultaneously conducting research and providing health care then one or the other activity will suffer. Today, such a division of research and teaching on the one hand and the provision of care on the other is international practice. It is the only way that the demands of innovative maximum care provision for our patients and those of often multicentric and international research can be fulfilled.
Students, too, would benefit from this arrangement since lecturers are seldom blessed with equal gifts as doctor, researcher and teacher.
Exceptional achievements in research and teaching should be encouraged by financial incentives.
If we as ophthalmologists intend to continue the scientific standards achieved in the second half of the 20th century then consolidation of all European research forces irrespective of national borders is imperative. Only in this way will it be possible to escape from non-European dominance.
Eastern Europe, as in the past, will make an important innovative contribution.
Team doctor model
In hospitals it is necessary to introduce a team doctor model in order to make interdisciplinary procedures more efficient, by means of the simultaneous involvement of qualified doctors from different disciplines.
Further vocational training in ophthalmology
The demands on the specialized knowledge of ophthalmologists is continually increasing.
In the European Union CME was founded by the Board of Ophthalmology. The Section Ophtalmologie of the Union Européenne Des Médecins Specialistes (UEMS) is designing a certification programme for ophthalmological training across the EU which is based mainly on American and British training regulations.
In agreement with other EU states, models are being discussed following those in the USA which limit the specialist qualification to 5 years -"Fixed Term Specialist". The successful completion of the further vocational training programme would enable the specialist qualification to be extended for a further 5 years.
Network thinking
As well as specialist competence, patient care and motivation, the ability to think in terms of a network is becoming increasingly important. Knowledge is a resource which is not depleted through use but rather increased.
The accumulation of the knowledge of all the doctors in the hospital or joint practices increases the chances of correct diagnosis and appropriate therapy. At the same time the use of technological networks such as the Internet and intranets is a prerequisite for the successful management of knowledge. The doctor is therefore required to develop a complete new work behaviour pattern and consciousness concerning integration without which optimal hospital and practice organization in the future will be unthinkable.
Patient information and patient rights
A major issue at the Council of Ministers committee for the health system in Amsterdam is the improvement of patient information and the observation of patient rights. If one wants 'responsible' patients, as it were, then they must have access to all medical information relevant to themselves. Doctors play a key role in supplying this information. They are capable of performing this counselling role only if they have access to the necessary innovative diagnostic and therapeutic knowledge as in evidence-based medicine. This means the conscious and sensible use of methods resulting from medical research.
Approximately half of the seriously ill seek a consultation when their illness is already at an advanced stage and the cost of treatment is higher. Increasing prevention in ophthalmology is therefore essential.
The patient should be thoroughly informed about examination results and actively involved in decisions regarding therapy. This form of patient involvement is already an everyday occurrence in the USA. Only the suitably informed patient is in the position to practise continuous health monitoring and to interpret early symptoms of an illness correctly.
Perspectives for the European health system
In the countries of the EU more than 70% of national law in some areas has already been replaced by EU law. This trend is becoming increasingly clear in the health system through the Maastricht and Amsterdam agreements. The progressive convergence of the health systems in the EU is inevitable. To date, however, the Council of Ministers and the caring professions have not even begun to agree about an integrated EU health system.
The European court of justice, by means of a judgement establishing a principle, has begun to regulate harmonization in partial areas which we must follow. It cannot be, however, that the EU court of justice reaches decisions about our interests and that we are neither willing nor able to play an active organizational role in the European health system through our medical committees and carry through our ideals concerning optimal patient care.
If this is difficult with 15 member states, how will it be in the near future when a further 15 middle European states join?
What does the new millennium hold in store for European ophthalmology? Those who expect serious answers will have to be content with conjecture. It is not about prognoses but rather the shape as well as the direction and pace of development.
The opening of the EU towards Eastern Europeand the advance of global thinking means that the way medicine presents itself must change from national and regional strategy to global and cross-cultural research and therapy application.
The strongest impulses in the opening of the EU towards the east come from intellectual advances, from knowledge and the ability to apply these to innovative medicine. The intellectual resources of these countries will optimise development, as was the case before World War II. It is these states which will enhance research on the basis of the existing level of medicine.
In the new millennium, through global research and its application, this infinitely expandable knowledge will have undreamt success in practical medicine. Computers and the discovery of cyberspace will instigate a gigantic learning process. The nonmaterial contribution, i.e. that which mankind explores and invents, will dominate material and technical advances.
Conclusion
The first millennium began with the geocentric world view of Ptolemy, followed, in 1500, by the heliocentric conception of Copernicus as doctor, theologian and astronomer. Now our expectations are focused on Homo symbioticus, as the researcher Joèl de Rosnay puts it, who -despite or because of enormous scientific progress -will develop undreamt of prospects. Man's rediscovery of his intellectual abilities will lead to his viewing the world as an entity, i.e. thinking and acting in a more longterm manner and with more perspectives than in the past.
We as doctors, bearing in mind the ever decreasing half-life of medical knowledge, should not let ourselves be intoxicated by diagnostic and therapeutic possibilities, neglecting the human capital which is the essence of our profession.
We have the enormous opportunity to contribute to the establishment of the new European health system. The financial resources will be available in the EU if we are successful in convincing the population of the value of their health.
The ERASMUS programme for student exchanges, followed by the opportunities to train assistant doctors in every EU state, the European specialist examination, and the future shared further education programme (CME) all stand for community and the transfer of knowledge. Let us use these instruments, which, unfortunately, were not available to my generation.
We will overcome the challenges ahead if we develop long-term strategies which are bound to the retention of our medical values.
In research and practice European ophthalmology must preserve its identity and position in the world.
